Post by
1hot-techwoman on Mar 27, 2024 10:25pm
Key Take away from Q Transcript :)
With the resolution of outstanding litigation, our balance sheet is clean and we enjoy $18 million in cash at year-end with less than $3 million of debt and full ownership of our assets, including 3 production facilities. 2023 saw the continuation of MediPharm's turnaround and financial restructuring, positioning us for further growth in 2024 and beyond.
Better times ahead for LABS !! :) $$$
Comment by
srtman03 on Mar 28, 2024 6:43am
They will be profitable by next Q and with no debt !!! Market always looks forward... $$$$$